<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>.04 Request for Information for Cost Review. | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/14.01/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/14.01/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|14|01|04|.04|"/>
    <meta itemprop="doc-type" content="section" data-document=""/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="14|01|04|.04" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/14.01.04.04"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content=".04 Request for Information for Cost Review. | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/14.01/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/14.01/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|14" data-search-heading="">
                  <a href="/us/md/exec/comar/14" title="Title 14 INDEPENDENT AGENCIES">Title 14 INDEPENDENT AGENCIES</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|14|01" data-search-heading="">
                  <a href="/us/md/exec/comar/14.01" title="Subtitle 01 PRESCRIPTION DRUG AFFORDABILITY BOARD">Subtitle 01 PRESCRIPTION DRUG AFFORDABILITY BOARD</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|14|01|04" data-search-heading="">
                  <a href="/us/md/exec/comar/14.01.04" title="Chapter 04 Cost Review Study Process">Chapter 04 Cost Review Study Process</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|14|01|04|.04" data-search-heading="">
                  <span title=".04 Request for Information for Cost Review.">.04 Request for Information for Cost Review.</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="14|01|04|.04">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/14.01.04.04">.04 Request for Information for Cost Review.</h1>
                <p class="text-indent-1 "><span class="level-num" id="A">A.</span> Request for Information.</p>
                <p class="text-indent-2 "><span class="level-num" id="A(1)">(1)</span> The Board shall post notice of the prescription drug product or products selected for cost review through the process outlined in <a class="internal-link " href="/us/md/exec/comar/14.01.04.03#I" title="">Regulation .03I of this chapter</a> on the Board’s website.</p>
                <p class="text-indent-2 "><span class="level-num" id="A(2)">(2)</span> To the extent there is no publicly available information to conduct an aspect of the statutory cost review, the Board may request information to conduct a cost review study under Health-General Article, §21-2C-09(a)(2), Annotated Code of Maryland, and this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="A(3)">(3)</span> The Board may request information by sending an email or postal mail to the manufacturer, PBMs, health insurance carriers, wholesale distributors, HMOs, and MCOs.</p>
                <p class="text-indent-2 "><span class="level-num" id="A(4)">(4)</span> The Board shall post notice of the request for information on its website.</p>
                <p class="text-indent-2 "><span class="level-num" id="A(5)">(5)</span> An entity that has not received a request for information from the Board may submit relevant information in accordance with this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="A(6)">(6)</span> Within 30 days of the date the request for information is posted to the website or transmitted to the entity, an entity may submit the information requested by the Board, and any other relevant information, in accordance with <a class="internal-link " href="/us/md/exec/comar/14.01.04.04#C" title="">§C of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="A(7)">(7)</span> An entity may request one 30-day extension of time to submit information under <a class="internal-link " href="/us/md/exec/comar/14.01.04.04#A(6)" title="">§A(6) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="A(8)">(8)</span> An entity shall submit the request for a 30-day extension to the Board in writing on or before the expiration of the initial submission period.</p>
                <p class="text-indent-1 "><span class="level-num" id="B">B.</span> For each prescription drug product under review, the Board may request the following information from:</p>
                <p class="text-indent-2 "><span class="level-num" id="B(1)">(1)</span> Manufacturer:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(a)">(a)</span> Documents and research explaining the relationship between the pricing of the prescription drug product and the cost of development, the relationship between the pricing of the prescription drug product and the therapeutic benefit, and information that is otherwise pertinent to the manufacturer’s pricing decision such as:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(1)(a)(i)">(i)</span> Life cycle management;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(1)(a)(ii)">(ii)</span> Net average price in the State; and</p>
                <p class="text-indent-4 "><span class="level-num" id="B(1)(a)(iii)">(iii)</span> The estimated value or cost-effectiveness of the prescription drug product;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(b)">(b)</span> The total amount of the price concessions, discounts, and rebates provided to each payor type operating in the State;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(c)">(c)</span> The total amount of the price concessions, discounts, and rebates the manufacturer is expected to provide to each payor type;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(d)">(d)</span> The net price received by manufacturers for the drug product in the State accounting for all price concessions, discounts, and rebates;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(e)">(e)</span> The units of the prescription drug product sold in the State;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(f)">(f)</span> The units of the prescription drug product sold nationally;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(g)">(g)</span> The total dollar amount of sales of the prescription drug product into the State;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(h)">(h)</span> The total dollar amount of sales of the prescription drug product nationally;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(i)">(i)</span> The invoice price per unit for the prescription drug product charged to purchasers in the United Kingdom, Germany, France, and Canada, reported in U.S. dollars;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(j)">(j)</span> Prices charged to purchasers in the State, including but not limited to pharmacies, pharmacy chains, pharmacy wholesalers, and other direct purchasers;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(k)">(k)</span> The average profit margin of the prescription drug product over the prior 5-year period and the projected profit margin anticipated for the current year for the prescription drug product;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(l)">(l)</span> Maryland and national gross and net manufacturer revenues for the prescription drug product under review for the most recent tax year;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(m)">(m)</span> Information concerning all authorized generics as defined by 42 CFR §447.502 for the prescription drug product;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(n)">(n)</span> Information concerning all other ANDAs, BLAs, and NDAs that pertain to the same active moiety and the same manufacturer;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(o)">(o)</span> The manufacturer’s research and development costs, as indicated on the manufacturer’s federal tax filing or information filed with the Federal Securities and Exchange Commission for the most recent tax year;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(p)">(p)</span> The portion of direct-to-consumer marketing costs eligible for favorable federal tax treatment in the most recent tax year that are specific to the prescription drug product under review; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(q)">(q)</span> Any additional factors or information the manufacturer proposes that the Board consider.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(2)">(2)</span> Health Insurance Carrier, HMO, and MCO:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(2)(a)">(a)</span> The total amount of the price concessions, discounts, and rebates the manufacturer provides to each health plan operating in the State, expressed as a percent of the WAC;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(2)(b)">(b)</span> The average price concession, discount, and rebate provided in the State for therapeutic alternatives;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(2)(c)">(c)</span> Placement in each formulary offered or administered in the State and the number of covered lives for each formulary;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(2)(d)">(d)</span> Benefit design around the prescription drug product, including copayment and coinsurance amounts in the State;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(2)(e)">(e)</span> The net cost incurred by the insurance carrier for the prescription drug product in the State; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(2)(f)">(f)</span> Any additional factors or information the health insurance carrier, HMO, or MCO proposes that the Board consider.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(3)">(3)</span> Pharmacy Benefits Managers:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(3)(a)">(a)</span> The therapeutic alternatives for the prescription drug product(s) under review identified by each formulary administered by the PBM;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(3)(b)">(b)</span> The total amount of the price concessions, discounts, and rebates the manufacturer provides to each PBM operating in the State, expressed as a percent of the WAC;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(3)(c)">(c)</span> The average price concession, discount, and rebate provided in the State for therapeutic alternatives;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(3)(d)">(d)</span> Placement in each formulary offered or administered in the State and the number of covered lives for each formulary;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(3)(e)">(e)</span> Benefit design around the prescription drug product, including copayment and coinsurance amounts;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(3)(f)">(f)</span> Maryland and national gross and net PBM revenues for the prescription drug product under review for the most recent tax year; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(3)(g)">(g)</span> Any additional factors or information the PBM proposes that the Board consider.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(4)">(4)</span> Wholesale Distributors:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(4)(a)">(a)</span> Prices charged to purchasers in the State, including but not limited to pharmacies, pharmacy chains, pharmacy wholesalers, and other direct purchasers;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(4)(b)">(b)</span> The total amount of price concessions and discounts provided by the wholesale distributor to purchasers in the State, including but not limited to pharmacies, pharmacy chains, pharmacy wholesalers, and other direct purchasers;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(4)(c)">(c)</span> Units of the prescription drug product sold in the State; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(4)(d)">(d)</span> Any additional factors or information the wholesale distributor proposes that the Board consider.</p>
                <p class="text-indent-1 "><span class="level-num" id="C">C.</span> Submission of Information.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(1)">(1)</span> An entity may submit the information requested in <a class="internal-link " href="/us/md/exec/comar/14.01.04.04#A" title="">§A of this regulation</a> by:</p>
                <p class="text-indent-3 "><span class="level-num" id="C(1)(a)">(a)</span> Completing the data form developed by the Board; and</p>
                <p class="text-indent-3 "><span class="level-num" id="C(1)(b)">(b)</span> Providing supporting documentation.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(2)">(2)</span> A person submitting information, including data and records, for the Board’s consideration shall comply with the procedures for designating confidential, trade-secret, and proprietary information set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/14.01.01.04" title=".04 Confidential, Trade-Secret, and Proprietary Information.">COMAR 14.01.01.04</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(3)">(3)</span> Information may be submitted to the Board:</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(a)">(a)</span> In paper form using a tracked common carrier, courier, or postal service; or</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(b)">(b)</span> Electronically using secure file transfer.</p>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/14.01.04.03" aria-label=".03 Selecting Drugs for Cost Review.">
                <div class="h__ui">Previous</div>
                <span>.03 Selecting Drugs for Cost Review.</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/14.01.04.05" aria-label=".05 Cost Review Study.">
                <div class="h__ui">Next</div>
                <span>.05 Cost Review Study.</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
